Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza for Remodulin infusion site pain in pulmonary arterial hypertension
2011-001312-59Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of capsaicin in pulmonary arterial hypertension (PAH) (2 arms), sponsored by Imperial College London. Primary endpoints: Safety and tolerability and Change in Numerical Pain Rating Scale. Started Apr 2011; status: completed.
02
Drugs
capsaicin
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2011-001312-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001312-59.